The optimal duration of endocrine therapy in hormone receptor-positive breast cancer

Clin Adv Hematol Oncol. 2021 Jun;19(6):383-404.NO ABSTRACTPMID:34106912
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Source Type: research